Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Next - 2. generation | 2016 - 2020 | Grand Solutions
|
|
|
Next - 2. generation
Period
2016 - 2020
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
15.83 Invested
30.4 mill. Budget
192.0 mill. Partners
Region Hovedstaden, Region Midt, Region Nord, Region Sjælland, Region Syd, Bioneer A/S, AstraZeneca A/S, Boehringer Ingelheim A/S, MSD Danmark ApS, Norvatis Healthcare A/S, Pcovery ApS, Roche A/S, RSPR Pharma AB, Serendex Pharmaceuticals A/S, Statens Serum Institut, Symphogen A/S, Clinical Trial Portfolio, OPEN Database, Non-allocated, Trial Nation People
BIONEER A/S
Read more about the project
| |||
| Next Generation Laser Photocoagulator: TRL 5 - TRL 8 | 2018 - 2019 | Innobooster
|
|
|
Next Generation Laser Photocoagulator: TRL 5 - TRL 8
Period
2018 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
2.4 mill. Budget
7.2 mill. Partners
Norlase ApS People
NORLASE ApS
Read more about the project
| |||
| NextProd: Next generation cell factories for industrial production by non-coding RNA manipulation | 2016 - 2021 | Grand Solutions
|
|
|
NextProd: Next generation cell factories for industrial production by non-coding RNA manipulation
Period
2016 - 2021
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
67.32 Invested
14.2 mill. Budget
21.1 mill. Partners
Københavns Universitet, Københavns Universitet, Novozymes A/S, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57 People
Københavns Universitet
Read more about the project
| |||
| Non-targeted fingerprinting analysis: A way to understand and monitor end-product quality in an enzyme recovery process | 2017 - 2021 | Industrial Researcher
|
|
|
Non-targeted fingerprinting analysis: A way to understand and monitor end-product quality in an enzyme recovery process
Period
2017 - 2021
Region
Region Hovedstaden Program
Erhvervsforsker Area
Biotek, Medico og Sundhed Investment
Percentage
41.58 Invested
1.1 mill. Budget
2.6 mill. Partners
University of Copenhagen, Novozymes A/S People
Novozymes A/S
Read more about the project
| |||
| NordForsk, Digitalisering Call 2019-2020 - CAPE | 2021 - 2023 | International collaborations
|
|
|
NordForsk, Digitalisering Call 2019-2020 - CAPE
Period
2021 - 2023
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
36.12 Invested
3.7 mill. Budget
10.4 mill. Partners
ITU, Malmö University, Malmö City Library, Aalto University , Helsinki City Library, AAU, Ballerup Library People
ITU
Read more about the project
| |||
| NordForsk, Digitalisering Call 2019-2020 - CUPP | 2021 - 2023 | International collaborations
|
|
|
NordForsk, Digitalisering Call 2019-2020 - CUPP
Period
2021 - 2023
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
29.47 Invested
2.6 mill. Budget
8.8 mill. Partners
ITU, University of LAT, Baltic Studies Centre, Tallinn University of Technology, Loughborough University, University of Oslo, PROSA People
ITU
Read more about the project
| |||
| NordForsk, Digitalisering Call 2019-2020 - SOS | 2021 - 2024 | International collaborations
|
|
|
NordForsk, Digitalisering Call 2019-2020 - SOS
Period
2021 - 2024
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
20.76 Invested
2.2 mill. Budget
10.8 mill. Partners
ITU, University of Agder, University of Gothenburg, DTU People
ITU
Read more about the project
| |||
| NordForsk, NordicPerMed - NORA | 2019 - 2022 | International collaborations
|
|
|
NordForsk, NordicPerMed - NORA
Period
2019 - 2022
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
12.6 Invested
3.5 mill. Budget
27.7 mill. Partners
Karolinska Institutet, Uppsala University, Linköping University, Rigshospitalet, Region H, Diakonhjemmet Hospital, Thermo Fisher Phadia AB, Elsa science AB, ZiteLab ApS People
Karolinska Institutet
Read more about the project
| |||
| NordForsk, NordicPerMed - NORD-TREAT | 2019 - 2023 | International collaborations
|
|
|
NordForsk, NordicPerMed - NORD-TREAT
Period
2019 - 2023
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
12.83 Invested
3.7 mill. Budget
29.0 mill. Partners
Örebro University (ORU), Oslo University Hospital (OUS), University in Oslo (UiO), University Hospital of Southern Jutland (SHS), Odense University Hospital (OUH), Nordic Bioscience, The National University Hospital of Iceland (LUH), University of Linköping (LiU) People
Örebro University (ORU)
Read more about the project
| |||
| NordForsk, NordicPerMed - NorDCaP | 2019 - 2021 | International collaborations
|
|
|
NordForsk, NordicPerMed - NorDCaP
Period
2019 - 2021
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
21.38 Invested
4.3 mill. Budget
20.1 mill. Partners
Aarhus University Hospital, DEFACTUM, Stavanger University Hospital, Karolinska Institutet, OncoAlgorithm, Mehiläinen, S:t Göran Hospital People
Aarhus University Hospital
Read more about the project
| |||
| NordForsk, NordicPerMed - PERAID | 2019 - 2023 | International collaborations
|
|
|
NordForsk, NordicPerMed - PERAID
Period
2019 - 2023
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
9.97 Invested
3.3 mill. Budget
33.4 mill. Partners
Karolinska Instituet, University of Bergen, St Olav’s Hospital, Rigshospitalet, Wageningen University & Research., LifeGlimmer GmbH People
Karolinska Instituet
Read more about the project
| |||
| NordForsk, NordicPerMed - PM-Heart | 2019 - 2023 | International collaborations
|
|
|
NordForsk, NordicPerMed - PM-Heart
Period
2019 - 2023
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
36.6 Invested
10.7 mill. Budget
29.4 mill. Partners
Rigshospitalet, KU, Danish National Genome Center, Norwegian University of Science and Technology, Oslo University Hospital, Rikshospitalet, deCODE genetics People
Rigshospitalet
Read more about the project
| |||
| Nordic COllaborative Health Biotech REgister Network for Covid-19 Epidemiology | 2020 - 2022 | International collaborations
|
|
|
Nordic COllaborative Health Biotech REgister Network for Covid-19 Epidemiology
Period
2020 - 2022
Region
Program
Internationale samarbejder Area
Biotek, Medico og Sundhed Investment
Percentage
39.95 Invested
2.8 mill. Budget
7.0 mill. Partners
KU, University of Oslo, Uppsala University, University of Strathclyde People
KU
Read more about the project
| |||
| Novel antimicrobials for the combat of Gram positive bacteria incl. Methicillin Resistant Staphylococcus aureus (MRSA) | 2019 - 2020 | Innoexplorer
|
|
|
Novel antimicrobials for the combat of Gram positive bacteria incl. Methicillin Resistant Staphylococcus aureus (MRSA)
Period
2019 - 2020
Region
Region Hovedstaden Program
Innoexplorer Area
Biotek, Medico og Sundhed Investment
Percentage
100 Invested
1.4 mill. Budget
1.4 mill. Partners
Københavns Universitet People
Københavns Universitet
Read more about the project
| |||
| Novel Enzyme Replacement Therapy in an Orphan Rare Disease | 2018 - 2020 | Innobooster
|
|
|
Novel Enzyme Replacement Therapy in an Orphan Rare Disease
Period
2018 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Biotek, Medico og Sundhed Investment
Percentage
33 Invested
370.012 Budget
1.1 mill. Partners
OrfoNeuro People
OrfoNeuro ApS
Read more about the project
| |||